| 2024 |
Fan CY, Wang SW, Chung C, Chen JY, Chang CY, Chen YC, Hsu TL, (Cheng TR, Wong CH*, Synthesis of a dendritic cell-targeted self-assembled polymeric nanoparticle for selective delivery of mRNA vaccines to elicit enhanced immune responses., Chemical science, vol. 15(29), 11626-11632, 2024 |
| 2024 |
Tseng YW, Yang TJ, Hsu YL, Liu JH, Tseng YC, Hsu TW, Lu Y, Pan SH, * (Cheng TR, *) Fang JM*, Dual-targeting compounds possessing enhanced anticancer activity via microtubule disruption and histone deacetylase inhibition., European journal of medicinal chemistry, vol. 265, 116042, 2024 |
| 2024 |
Wang CW, Tsai HY, Hsu C, Hsieh CC, Wang IS, (Chang CF, Su NW, Structure-specific metabolism of flavonol molecules by Bacillus subtilis var. natto BCRC 80517., Food chemistry, vol. 430, 136975, 2024 |
| 2024 |
Hsu PH, Hazam PK, Huang YP, Yeh JC, Chen YR, Li CC, (Chang CF, Liou JW, Chen JY, Sequential rearrangement and stereochemical reorganization to design an antimicrobial peptide with enhanced stability., Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, vol. 170, 116088, 2024 |
| 2024 |
Hsu PH, Hazam PK, Huang YP, Yeh JC, Chen YR, Li CC, (Chang CF, Liou JW, Chen JY, Optimization of sequence and chiral content enhances therapeutic potential of tilapia piscidin peptides., European journal of medicinal chemistry, vol. 265, 116083, 2024 |
| 2024 |
Tsai TY, Jhang WT, Hsu HK, Chan YT, (Chang CF, Chen YR, Amyloid Modifier SERF1a Accelerates Alzheimer's Amyloid-β Fibrillization and Exacerbates the Cytotoxicity., ACS chemical neuroscience, vol. 15(3), 479-490, 2024 |
| 2024 |
Lin GM, Yu TA, (Chang CF, Hsu CH, Proline Isomerization and Molten Globular Property of TgPDCD5 Secreted from Toxoplasma gondii Confers Its Regulation of Heparin Sulfate Binding., JACS Au, vol. 4(5), 1763-1774, 2024 |
| 2024 |
Lai CH, Ko KT, Fan PJ, Yu TA, (Chang CF, Draczkowski P, Hsu SD, Structural insight into the ZFAND1-p97 interaction involved in stress granule clearance., The Journal of biological chemistry, vol. 300(5), 107230, 2024 |
| 2024 |
Lin SM, Huang HT, Fang PJ, (Chang CF, Satange R, Chang CK, Chou SH, Neidle S, Hou MH, Structural basis of water-mediated cis Watson-Crick/Hoogsteen base-pair formation in non-CpG methylation., Nucleic acids research, vol. 52(14), 8566-8579, 2024 |
| 2024 |
Lin TC, Shih O, Tsai TY, Yeh YQ, Liao KF, Mansel BW, Shiu YJ, (Chang CF, Su AC, Chen YR, Jeng US, Binding structures of SERF1a with NT17-polyQ peptides of huntingtin exon 1 revealed by SEC-SWAXS, NMR and molecular simulation., IUCrJ, vol. 11(Pt 5), 849-858, 2024 |
| 2024 |
Lin HC, Jeng WJ, (Yang HI*, Response to Chen and Liaw., CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, vol. 15(3), e00663, 2024 |
| 2024 |
Chen YJ, Hsiao TH, Lin YC, Jeng WJ, Mao CL, Wei CY, Hsieh YC, Huang CJ, Pan MH, Chen IC, Lin CH, Chen YM, (Yang HI*, Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort., RMD OPEN, vol. 10(2), e003293, 2024 |
| 2024 |
Lin HC, Jeng WJ, Liu J, Pan MH, Lee MH, Batrla-Utermann R, Lu SN, Chen CF, (Yang HI*, Chen CJ, Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 59(8), 993-1002, 2024 |
| 2024 |
Shen HC, Pan MH, Huang CJ, Yeh HY, (Yang HI*, Lin YH, Huang CC, Lee KC, Yang YY, Hou MC, Multiple genetic polymorphisms are associated with the risk of metabolic syndrome, fatty liver, and airflow limitation: A Taiwan Biobank study., GENE, vol. 927, 148660, 2024 |
| 2024 |
Lin HC, Jeng WJ, (Yang HI*, Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients-Authors' reply., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 59(11), 1459-1461, 2024 |
| 2024 |
Lu TY, Wu CD, Huang YT, Chen YC, Chen CJ, (Yang HI, Pan WC*, Exposure to PM(2.5) Metal Constituents and Liver Cancer Risk in REVEAL-HBV., Journal of epidemiology, vol. 34(2), 87-93, 2024 |
| 2024 |
Lin HC, Jeng WJ, (Yang HI*, Editorial: High qHBsAg-Is it a good or bad signal? Authors' reply., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 59(12), 1618-1619, 2024 |
| 2024 |
Teng W, Chang TT, (Yang HI, Peng CY, Su CW, Su TH, Hu TH, Yu ML, Yang HC, Wu JC, Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines., HEPATOLOGY INTERNATIONAL, vol. 18(3), 1066, 2024 |
| 2024 |
Huang JF, Chang TJ, Yeh ML, Shen FC, Tai CM, Chen JF, Huang YH, Hsu CY, Cheng PN, Lin CL, Hung CH, Chen CC, Lee MH, Lee CC, Lin CW, Liu SC, (Yang HI, Chien RN, Kuo CS, Peng CY, Chang ML, Huang CF, Yang YS, Yang HC, Lin HC, Ou HY, Liu CJ, Tseng CH, Kao JH, Chuang WL, Huang CN, Chen PJ, Wang CY, Yu ML, Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus., HEPATOLOGY COMMUNICATIONS, vol. 8(11), e0571, 2024 |
| 2024 |
Lee MH, Chen YT, Huang YH, Lu SN, Yang TH, Huang JF, Yin SC, Yeh ML, Huang CF, Dai CY, Chuang WL, Yu ML, (Yang HI, Chen HY, Chen CJ, Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC., CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, vol. S1542-3565(24)00198-8, doi: 10.1016/j.cgh.2024.01.045, 2024 |
| 2024 |
Polaris Observatory Collaborators, (Yang HI); et al, Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories., Journal of hepatology, vol. 80(2), 232-242, 2024 |
| 2024 |
Kim GA, Lim YS, Han S, Choi GH, Choi WM, Choi J, Sinn DH, Paik YH, Lee JH, Lee YB, Cho JY, Heo NY, Yuen MF, Wong VW, Chan SL, (Yang HI, Chen CJ, Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B : A Multinational Study for the Development and External Validation of a New Prognostic Model., ANNALS OF INTERNAL MEDICINE, vol. 177(10), 1308-1318, 2024 |
| 2024 |
Chen YT, Chen TI, Yang TH, Yin SC, Lu SN, Liu XR, Gao YZ, Lin CJ, Huang CW, Huang JF, Yeh ML, Huang CF, Dai CY, Chuang WL, (Yang HI, Yu ML, Lee MH, Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes., AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024 |
| 2024 |
Huang YT, Hsu YC, (Yang HI, Lee MH, Lai TH, Chen CJ, Huang YT, Causal mediation analyses for the natural course of hepatitis C: a prospective cohort study., JOURNAL OF EPIDEMIOLOGY, 2024 |
| 2024 |
Cai YH, Wang CC, Hsiao CH, (Wang YS)*, Experimental Validation of Comprehensive Calculation for High-Resolution Linear MALDI-TOF Mass Spectrometry., Journal of the American Society for Mass Spectrometry, vol. 35(5), 992-998, 2024 |
| 2024 |
Chang Ko‐Keng, Ko Yi‐Yu, Chou Po‐Yu, Lai Szu‐Hsueh, (Wang Yi‐Sheng)*, MAXTOF: An efficient calculation tool for precise optimization of MALDI-TOF MS measurements in real time‐TOF MS measurements in real time, Journal of the Chinese Chemical Society, vol. 71(8) 932-941, 2024 |
| 2024 |
Huang, Y.K., W.C. Cheng, J.C. Yang, Y.C. Wu, H.H. Wu, T.T. Kuo, C.C. Lo, C.Y. Hsieh, S.C. Wong, C.H. Lu, (C.N. Shen, M.C. Hung, J.T. Lin, C.C. Yeh, Y.P. Sher., Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy, Nature Cancer, vol. 5(3), 400-419, 2024 |
| 2024 |
Panda SS, Lee CC, Geevimaan K, Chen KC, Yang SH, (Shen CN, HuangFu WC, Wu HC, Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression., Journal of biomedical science, vol. 31(1), 72, 2024 |
| 2024 |
Chang PS, Chen YC, Hua WK, Hsu JC, Tsai JC, Huang YW, Kao YH, Wu PH, Wang PN, Chang YF, Chang MC, Chang YC, Jian SL, Lai JS, Lai MT, Yang WC, (Shen CN, Wen KK, Wu SC, Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system., PloS one, vol. 19(8), e0309245, 2024 |
| 2024 |
Chen X, Mohapatra A, Nguyen HTV, Schimanski L, Kit TT, Rijal P, Chen CP, Cheng SH, Lee WH, Chou YC, Townsend AR, (Ma C, Huang KYA, The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine, PLOS Pathogens, vol. 20(6), e1012246, 2024 |
